Inhibition of antigen presentation and T cell costimulation blocks PTH-induced bone loss.
T cells are required for continuous parathyroid hormone (cPTH) treatment to induce bone loss as they sensitize stromal cells to PTH through CD40 ligand (CD40L), a surface molecule of activated T cells. Since CD40L expression is a feature of activated T cells, we investigated whether antigen (Ag)-mediated T cell activation is required for PTH to exert its catabolic activity. We report that inhibition of Ag presentation through silencing of either class I or class II MHC-T cell receptor (TCR) interaction prevents the cortical bone loss induced by in vivo cPTH treatment. We also show that the bone loss and the stimulation of bone resorption induced by cPTH treatment are prevented by CTLA4-Ig, an inhibitor of T cell costimulation approved for the treatment of rheumatoid arthritis. Since inhibition of antigen-driven T cell activation by blockade of either TCR signaling or T cell costimulation is sufficient to silence the catabolic activity of cPTH, antigen-presenting cells and T lymphocyte interactions therefore play a critical role in the mechanism of action of PTH.
Bedi
Brahmchetna
B
Department of Medicine, Emory University, Atlanta, Georgia, USA.
Li
Jau-Yi
JY
Grassi
Francesco
F
Tawfeek
Hesham
H
Weitzmann
M Neale
MN
Pacifici
Roberto
R
D000069594:Abatacept; D000818:Animals; D017951:Antigen Presentation / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000378:metabolism; D001862:Bone Resorption / Q000139:chemically induced* / Q000517:prevention & control*; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism; D015536:Down-Regulation / Q000187:drug effects / Q000235:genetics / Q000276:immunology; D005260:Female; D018796:Immunoconjugates / Q000494:pharmacology* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use; D008213:Lymphocyte Activation / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D010281:Parathyroid Hormone / Q000009:adverse effects*; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology
D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D010281:Parathyroid Hormone; D000069594:Abatacept
Bone. 2007 Jan;40(1):169-74
16876496
Immunol Cell Biol. 1998 Feb;76(1):34-40
9553774
Clin Endocrinol (Oxf). 1996 Jun;44(6):697-702
8759182
J Bone Miner Res. 1992 Jan;7(1):65-72
1532281
Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15087-92
17848519
J Clin Invest. 2001 Feb;107(3):277-86
11160151
J Bone Miner Res. 1991 Jan;6(1):85-93
2048435
J Clin Invest. 2007 Jan;117(1):122-32
17173138
Science. 1996 Apr 5;272(5258):54-60
8600537
J Exp Med. 1997 Oct 6;186(7):1099-106
9314558
Cell. 1994 Jan 14;76(1):17-27
8287475
N Engl J Med. 1998 Jun 18;338(25):1813-21
9632449
Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16711-2
15557556
J Bone Miner Res. 2001 Jul;16(7):1300-7
11450706
Endocrinology. 2003 May;144(5):1761-9
12697681
Cell Metab. 2008 Aug;8(2):132-45
18680714
Annu Rev Immunol. 1993;11:213-44
8476560
Nephron. 1993;64(4):592-9
8396211
N Engl J Med. 1986 Jun 26;314(26):1676-86
3520321
Nat Immunol. 2001 Oct;2(10):932-8
11561182
Endocrinology. 1999 Aug;140(8):3552-61
10433211
Endocrinology. 1999 Oct;140(10):4683-90
10499526
Nephron. 1995;70(1):21-4
7617112
J Biol Chem. 1984 May 10;259(9):5531-5
6325439
Nature. 2002 Nov 28;420(6914):429-34
12459785
Endocrinology. 2001 Sep;142(9):4047-54
11517184
J Clin Endocrinol Metab. 1996 Oct;81(10):3450-4
8855783
Science. 1992 Aug 7;257(5071):792-5
1496399
Am J Physiol Endocrinol Metab. 2005 Nov;289(5):E784-93
15956054
Immunol Rev. 2005 Dec;208:207-27
16313351
Nature. 1999 Nov 18;402(6759):304-9
10580503
Crit Rev Oral Biol Med. 2001;12(2):125-35
11345523
Science. 1997 Jun 27;276(5321):2057-62
9197272
J Clin Endocrinol Metab. 1999 May;84(5):1562-6
10323380
J Endocrinol. 2005 Sep;186(3):549-57
16135674
J Clin Invest. 1995 Sep;96(3):1238-44
7657797
Pediatr Res. 1995 Apr;37(4 Pt 1):507-11
7596693
Bone. 1995 Apr;16(4):477-84
7605709
Endocr Rev. 2002 Jun;23(3):279-302
12050121
Endocrinology. 1986 Oct;119(4):1654-9
3463505
J Cell Biochem. 2003 May 1;89(1):180-90
12682918
Endocrinology. 1986 Feb;118(2):824-8
3455914
Immunol Rev. 1993 Jun;133:45-73
8225370
Int Immunol. 1992 Sep;4(9):969-74
1390439
Semin Immunol. 2000 Jun;12(3):197-203; discussion 257-344
10910740
Immunol Rev. 2005 Dec;208:154-68
16313347
J Clin Endocrinol Metab. 1996 Oct;81(10):3487-91
8855790
Immunology. 2003 Mar;108(3):296-304
12603595
Trends Endocrinol Metab. 2004 Mar;15(2):60-5
15036251
Endocrinology. 1992 Jan;130(1):300-6
1309334